Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Merck
Accenture
Deloitte
Boehringer Ingelheim
Argus Health
Farmers Insurance
Cipla
Johnson and Johnson
Healthtrust

Generated: February 23, 2018

DrugPatentWatch Database Preview

ZANTAC Drug Profile

« Back to Dashboard

US Patents and Regulatory Information for ZANTAC

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Teligent ZANTAC ranitidine hydrochloride INJECTABLE;INJECTION 019090-001 Oct 19, 1984 AP RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Sanofi Us ZANTAC 150 ranitidine hydrochloride TABLET;ORAL 021698-001 Aug 31, 2004 OTC Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Glaxo Grp Ltd ZANTAC 150 ranitidine hydrochloride GRANULE, EFFERVESCENT;ORAL 020251-002 Mar 31, 1994 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Sanofi Us ZANTAC 75 ranitidine hydrochloride TABLET, EFFERVESCENT;ORAL 020745-001 Feb 26, 1998 DISCN Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Sanofi Us ZANTAC 150 ranitidine hydrochloride TABLET;ORAL 021698-002 Mar 13, 2007 OTC Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Teligent ZANTAC IN PLASTIC CONTAINER ranitidine hydrochloride INJECTABLE;INJECTION 019593-002 Sep 27, 1991 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Glaxo Grp Ltd ZANTAC ranitidine hydrochloride SYRUP;ORAL 019675-001 Dec 30, 1988 AA RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Glaxosmithkline ZANTAC 150 ranitidine hydrochloride CAPSULE;ORAL 020095-001 Mar 8, 1994 DISCN Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Glaxo Grp Ltd ZANTAC 150 ranitidine hydrochloride TABLET;ORAL 018703-001 Jun 9, 1983 AB RX Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Glaxo Grp Ltd ZANTAC 150 ranitidine hydrochloride TABLET, EFFERVESCENT;ORAL 020251-001 Mar 31, 1994 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for ZANTAC

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Teligent ZANTAC ranitidine hydrochloride INJECTABLE;INJECTION 019090-001 Oct 19, 1984 ➤ Sign Up ➤ Sign Up
Glaxo Grp Ltd ZANTAC ranitidine hydrochloride SYRUP;ORAL 019675-001 Dec 30, 1988 ➤ Sign Up ➤ Sign Up
Glaxo Grp Ltd ZANTAC ranitidine hydrochloride SYRUP;ORAL 019675-001 Dec 30, 1988 ➤ Sign Up ➤ Sign Up
Glaxo Grp Ltd ZANTAC ranitidine hydrochloride SYRUP;ORAL 019675-001 Dec 30, 1988 ➤ Sign Up ➤ Sign Up
Glaxo Grp Ltd ZANTAC ranitidine hydrochloride SYRUP;ORAL 019675-001 Dec 30, 1988 ➤ Sign Up ➤ Sign Up
Teligent ZANTAC ranitidine hydrochloride INJECTABLE;INJECTION 019090-001 Oct 19, 1984 ➤ Sign Up ➤ Sign Up
Teligent ZANTAC ranitidine hydrochloride INJECTABLE;INJECTION 019090-001 Oct 19, 1984 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Paragraph IV (Patent) Challenges for ZANTAC
Drugname Dosage Strength RLD Submissiondate
➤ Subscribe Tablets 150 mg ➤ Subscribe 10/30/2007

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
Harvard Business School
Boehringer Ingelheim
Cantor Fitzgerald
McKesson
Chinese Patent Office
Covington
Dow
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot